138 related articles for article (PubMed ID: 9060535)
1. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.
Loprinzi CL; Abu-Ghazaleh S; Sloan JA; vanHaelst-Pisani C; Hammer AM; Rowland KM; Law M; Windschitl HE; Kaur JS; Ellison N
J Clin Oncol; 1997 Mar; 15(3):969-73. PubMed ID: 9060535
[TBL] [Abstract][Full Text] [Related]
2. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer.
Juraskova I; Jarvis S; Mok K; Peate M; Meiser B; Cheah BC; Mireskandari S; Friedlander M
J Sex Med; 2013 Oct; 10(10):2549-58. PubMed ID: 23635341
[TBL] [Abstract][Full Text] [Related]
3. Effect of a pH-Balanced Vaginal Gel on Dyspareunia and Sexual Function in Breast Cancer Survivors Who Were Premenopausal at Diagnosis: A Randomized Controlled Trial.
Kim YH; Park S; Lee M; Hahn S; Jeon MJ
Obstet Gynecol; 2017 May; 129(5):870-876. PubMed ID: 28383379
[TBL] [Abstract][Full Text] [Related]
4. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the moisturization efficacy of two vaginal moisturizers: Pectin versus polycarbophil technologies.
Caswell M; Kane M
J Cosmet Sci; 2002; 53(2):81-7. PubMed ID: 11919643
[TBL] [Abstract][Full Text] [Related]
6. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.
Bygdeman M; Swahn ML
Maturitas; 1996 Apr; 23(3):259-63. PubMed ID: 8794418
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.
Vale F; Rezende C; Raciclan A; Bretas T; Geber S
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618
[TBL] [Abstract][Full Text] [Related]
8. Comparative study: Replens versus local estrogen in menopausal women.
Nachtigall LE
Fertil Steril; 1994 Jan; 61(1):178-80. PubMed ID: 8293835
[TBL] [Abstract][Full Text] [Related]
9. Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial.
Lee YK; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Obstet Gynecol; 2011 Apr; 117(4):922-927. PubMed ID: 21422866
[TBL] [Abstract][Full Text] [Related]
10. Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women.
Mitchell CM; Guthrie KA; Larson J; Diem S; LaCroix AZ; Caan B; Shifren JL; Woods NF; Heiman JR; Lindau ST; Reed SD
Menopause; 2019 Aug; 26(8):816-822. PubMed ID: 30994576
[TBL] [Abstract][Full Text] [Related]
11. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.
Portman D; Palacios S; Nappi RE; Mueck AO
Maturitas; 2014 Jun; 78(2):91-8. PubMed ID: 24679891
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a vaginal moisturizer in baboons with decreasing ovarian function.
Hubbard GB; Carey KD; Levine H; Bachmann GA
Lab Anim Sci; 1997 Feb; 47(1):36-9. PubMed ID: 9051645
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial].
Bazin S; Lefebvre J; Fortier M; Brisson J; Brouillette F; Bujold E; Bouchard C
J Obstet Gynaecol Can; 2011 Aug; 33(8):838-843. PubMed ID: 21846439
[TBL] [Abstract][Full Text] [Related]
14. Effect of fennel vaginal cream on sexual function in postmenopausal women: A double blind randomized controlled trial.
Abedi P; Najafian M; Yaralizadeh M; Namjoyan F
J Med Life; 2018; 11(1):24-28. PubMed ID: 29696061
[No Abstract] [Full Text] [Related]
15. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
[TBL] [Abstract][Full Text] [Related]
16. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.
Bachmann GA; Komi JO;
Menopause; 2010; 17(3):480-6. PubMed ID: 20032798
[TBL] [Abstract][Full Text] [Related]
17. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry.
van der Laak JA; de Bie LM; de Leeuw H; de Wilde PC; Hanselaar AG
J Clin Pathol; 2002 Jun; 55(6):446-51. PubMed ID: 12037029
[TBL] [Abstract][Full Text] [Related]
18. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause.
Wurz GT; Kao CJ; DeGregorio MW
Clin Interv Aging; 2014; 9():1939-50. PubMed ID: 25419123
[TBL] [Abstract][Full Text] [Related]
20. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P
Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
